Medpace Holdings, Inc.
MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and develā¦ read more
Healthcare
Diagnostics & Research
9 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$476.69
Price-1.83%
-$8.90
1Y
Price
Market Cap
$13.392b
Large
Price/Earnings 3y Avg5y Avg
35.4x
Premium
Premium
Financials Overview
Key metrics over the past few years+19.5%
EBITDA Margin+15.0%
Net Profit Margin+23.6%
Free Cash Flow MarginRevenue
$2.232b
+5.8%
1y CAGR+15.6%
3y CAGR+18.7%
5y CAGREarnings
$418.299m
+3.4%
1y CAGR+20.6%
3y CAGR+24.2%
5y CAGREPS
$13.45
+6.5%
1y CAGR+23.6%
3y CAGR+30.5%
5y CAGRBook Value
$172.351m
$1.572b
Assets$1.399b
Liabilities$124.946m
DebtDebt to Assets
8.0%
0.2x
Debt to EBITDAFree Cash Flow
$579.816m
+1.3%
1y CAGR+19.5%
3y CAGR+27.0%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company